KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Share-based Compensation (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Share-based Compensation data on record, last reported at $17.6 million in Q4 2025.

  • For Q4 2025, Share-based Compensation rose 2.3% year-over-year to $17.6 million; the TTM value through Dec 2025 reached $71.1 million, up 1.71%, while the annual FY2025 figure was $71.1 million, 1.71% up from the prior year.
  • Share-based Compensation reached $17.6 million in Q4 2025 per CRL's latest filing, down from $23.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $23.3 million in Q3 2025 and bottomed at $13.1 million in Q1 2025.
  • Average Share-based Compensation over 5 years is $17.9 million, with a median of $17.2 million recorded in 2021.
  • Peak YoY movement for Share-based Compensation: surged 30.55% in 2021, then fell 21.53% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $19.2 million in 2021, then grew by 15.03% to $22.1 million in 2022, then fell by 11.55% to $19.5 million in 2023, then fell by 11.71% to $17.2 million in 2024, then rose by 2.3% to $17.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $17.6 million in Q4 2025, $23.3 million in Q3 2025, and $17.0 million in Q2 2025.